Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder
Adding Motivational Interviewing to Cognitive Behavioural Therapy for Severe Generalized Anxiety Disorder
1 other identifier
interventional
85
1 country
2
Brief Summary
The current study examines whether change-readiness, and consequently treatment outcome, can be enhanced in Cognitive Behavioral Therapy (CBT) for severe Generalized Anxiety Disorder (GAD) by adding a brief course of Motivational Interviewing (MI adapted for anxiety, Westra \& Dozois, 2003) before and during CBT when motivation wanes. 106 individuals with severe GAD will be randomly assigned to receive an equal number of sessions of either MI and CBT (MI-CBT arm) or CBT alone (CBT alone arm). It is expected that the MI-CBT arm relative to the CBT alone arm will show lower levels of resistance in CBT, higher levels of homework compliance and therapeutic alliance, better moment-to-moment interpersonal process, and consequently superior outcomes - both post-treatment and at 6 and 12 month follow-ups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2011
CompletedFirst Posted
Study publicly available on registry
December 8, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 29, 2015
December 1, 2015
3.9 years
December 6, 2011
December 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Penn State Worry Questionnaire (PSWQ)
The Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990) is a widely used measure of worry in GAD treatment outcome studies. It is a 16-item scale assessing trait worry. The PSWQ has been found to possess high internal consistency and temporal stability, as well as good convergent and discriminant validity. It also differentiates individuals with GAD from those with other anxiety disorders (Brown et al., 1992).
up to 4 years
Secondary Outcomes (3)
Satisfaction with Life Scale (SWLS)
up to 4 years
Inventory of Interpersonal Problems (IIP)
up to 4 years
Depression Anxiety Stress Scale (DASS)
up to 4 years
Study Arms (2)
MI-CBT
ACTIVE COMPARATORCBT alone
ACTIVE COMPARATORInterventions
Participants with a diagnosis of severe Generalized Anxiety Disorder will be randomly assigned to receive either 4 weekly sessions of MI followed by 11 weekly sessions of CBT (MI-CBT arm) or 15 weekly sessions of CBT (CBT alone arm). Both groups will also receive 2 follow-up CBT treatment sessions at 1 and 3 months post-treatment. In order to increase generalizability to clinical practice, in the CBT phase for the MI-CBT arm, therapists will shift to MI in the presence of empirically derived markers of resistance and shift back to CBT when resistance has diminished. In the CBT alone arm therapists will respond to resistance using manualized recommendations derived from leading CBT theorists for the management of resistance.
Eligibility Criteria
You may qualify if:
- Between 16 \& 65 years of age
- Proficient use of English
- A principle diagnosis of Generalized Anxiety Disorder (GAD)
- Severe GAD (as measured by clinician severity ratings and PSWQ)
- Willingness to either remain on stable dosage of psychotropic medication or remain unmedicated throughout their involvement in the clinical trial
You may not qualify if:
- Current of history of psychotic spectrum disorder or bipolar mood disorder
- Cognitive impairment such as neurodegenerative illness or head injury
- Current substance abuse and or dependance
- Concurrent psychotherapy, either individual or group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- York Universitylead
- Toronto Metropolitan Universitycollaborator
- University of Massachusetts, Amherstcollaborator
Study Sites (2)
York University
Toronto, Ontario, M3J 1P3, Canada
Ryerson University
Toronto, Ontario, M5B 2K3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henny A Westra, Ph.D.
York University
- PRINCIPAL INVESTIGATOR
Martin M Antony, Ph.D.
Toronto Metropolitan University
- PRINCIPAL INVESTIGATOR
Michael J Constantino, Ph.D.
University of Massachusetts, Worcester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist, Associate Professor (York University)
Study Record Dates
First Submitted
December 6, 2011
First Posted
December 8, 2011
Study Start
January 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 29, 2015
Record last verified: 2015-12